US Broker Ratings

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with a Forward P/E of 51.72

Warby Parker Inc. (NYSE: WRBY), a notable player in the healthcare sector, particularly in the medical instruments and supplies industry, continues to draw investor interest with..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking a 44% Potential Upside in the Healthcare Sector

Perrigo Company plc (PRGO), a healthcare stalwart based in Ireland, is capturing investor attention with its intriguing valuation metrics and a significant 44.27% potential upside according..

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing a 36.62% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY), a significant player in the healthcare industry, operates a robust network of surgical facilities across the United States. As investors seek..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Promising 64.85% Upside Potential for the Surgical Robotics Leader

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is carving a significant niche in the healthcare sector with its innovative approach to urological solutions. As a pivotal player in..

Sotera Health Company (SHC) Stock Analysis: Navigating a 6.4% Revenue Growth in the Diagnostics & Research Sector

Sotera Health Company (NASDAQ: SHC) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Broadview Heights, Ohio,..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a Challenging Landscape with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a tech-driven healthcare company, is capturing headlines with its impressive 29% revenue growth. Operating within the competitive healthcare plans sector, Oscar..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 53.85% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making headlines with a notable potential upside of 53.85%, capturing the attention of investors seeking growth opportunities in the..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth Amidst Market Fluctuations

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector, continues to leverage its extensive footprint in the medical instruments and supplies industry. Headquartered..

Avidity Biosciences (RNA): Investor Outlook with 43.84% Potential Upside in Pioneering RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA), a trailblazer in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to RNA therapeutics...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Navigating Strong Revenue Growth Amidst Mixed Analyst Ratings

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing the attention of investors with its impressive revenue growth and strategic partnerships...

TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking a 23.77% Potential Upside for Investors

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.92 billion, this..

Lantheus Holdings (LNTH) Stock Analysis: A 60% Potential Upside Beckons in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the niche market of diagnostic and therapeutic..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Robust 92.91% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 92.91%. Specializing in the..

Nuvalent, Inc. (NUVL): Investor Outlook Highlights Potential 52.66% Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves within the healthcare sector, particularly in biotechnology. Headquartered in Cambridge, Massachusetts, this innovative firm is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Promising 21.9% Upside Potential in the Biotech Space

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is turning heads in the biotechnology sector with its ambitious approach to addressing genetic diseases and cancers. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Investor Outlook on a 38.93% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, offers investors an intriguing opportunity with a noteworthy 38.93% potential upside based on current..

Solventum Corporation (SOLV) Stock Analysis: Navigating a Potential 18.64% Upside in the Medical Instruments Sector

Solventum Corporation (SOLV), a prominent player in the healthcare sector, stands out with its diverse portfolio of medical instruments and supplies. Headquartered in Maplewood, Minnesota, Solventum..

Bio-Techne Corp (TECH) Stock Analysis: A 19.55% Potential Upside in the Biotech Sector

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology industry, is drawing attention from investors with a potential upside of 19.55% based on current analyst..

Repligen Corporation (RGEN) Investor Outlook: Exploring the 46.93% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, continues to capture investor attention with its innovative contributions to the medical instruments and supplies..

Integer Holdings Corporation (ITGR) Stock Analysis: Unveiling a 30.60% Potential Upside in the Medical Device Landscape

Integer Holdings Corporation (NYSE: ITGR), with its roots firmly planted in the healthcare sector, operates as a significant player in the medical devices industry. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds